companydata.dkcompanydata.dk

Thermo Fisher Diagnostics ApS: Financial statements 2022

CVR: 27640745

Source: annual report 2022, Danish Business Authority

01/01/2022 – 31/12/2022

Thermo Fisher Diagnostics ApS (CVR 27640745) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 44,114,000 and a net result of DKK 12,562,000 compared with DKK 1,165,000 the year before. That is an increase of 33.3% compared with the year before. Equity in the 2022 report amounted to DKK 56,455,000. The solvency ratio was 60.9%. The company had 28 employees in the financial year.

Gross Profit
DKK 44,114,000
Profit/Loss
DKK 12,562,000
Equity
DKK 56,455,000
Total Assets
DKK 92,727,000
Employees
28

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022-44.1M12.6M56.5M28
2021-33.1M1.2M43.9M31
2020-34.7M5M42.7M35
2019-35.9M7.5M37.7M31
2018-34.6M8.4M30.1M27

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on Thermo Fisher Diagnostics ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

Thermo Fisher Diagnostics ApS: The 2021 annual report is outJun 27, 2022

Thermo Fisher Diagnostics ApS has published its annual report for 2021. Gross profit came to DKK 33,084,000, and the net result was DKK 1,165,000.

Michael Toftvad joins the board of Thermo Fisher Diagnostics ApSJun 10, 2022

As of June 10, 2022, Michael Toftvad has joined the board of directors of Thermo Fisher Diagnostics ApS.

Bo Kühnel Matthisson leaves the board of Thermo Fisher Diagnostics ApSJun 10, 2022

As of June 10, 2022, Bo Kühnel Matthisson has left the board of directors of Thermo Fisher Diagnostics ApS.

About Thermo Fisher Diagnostics ApS

Thermo Fisher Diagnostics ApS is a Danish company of the type Anpartsselskab based in Allerød, founded in 2004. The company is registered under the industry Engroshandel med andre maskiner og andet udstyr. The company was previously named PHADIA ApS and SWEDEN DIAGNOSTICS (DENMARK), ApS. The management consists of Pia Finnemann-Andersen. The board consists of Petrus Thomas Adrianus van der Zande (chair), Pia Finnemann-Andersen and Simon Lie. The company is owned by Thermo Fisher Scientific Beteiligungsverwaltungs GmbH. The company has 24 employees (2026). In 2025, the company reported a gross profit of DKK 34,059,000 and a net result of DKK 5,450,000 compared with DKK 6,358,000 the year before. Equity in the 2025 report amounted to DKK 74,863,000.

Source: annual report 2025, Danish Business Authority